SAN DIEGO (AP) — SAN DIEGO (AP) — Capricor Therapeutics Inc. (CAPR) on Monday reported a loss of $9.8 million in its first quarter.
On a per-share basis, the San Diego-based company said it had a loss of 31 cents.
The biotechnology company posted revenue of $4.9 million in the period.
Capricor shares have risen 11% since the beginning of the year. In the final minutes of trading on Monday, shares hit $5.44, a rise of 32% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CAPR at https://www.zacks.com/ap/CAPR
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
